Varex Imaging's Q2 Earnings: A Mixed Picture Amidst Tariff Turmoil

SALT LAKE CITY, May 8, 2025 ? Varex Imaging Corporation (Nasdaq: VREX) has just unveiled its unaudited financial results for the second quarter of fiscal year 2025, and let?s just say, it?s a tale of two segments.

Revenue Forecast: A Solid Quarter but a Cloudy Outlook

The company reported revenues of $213 million, reflecting a modest 3% increase year-over-year. While this aligns with the EPS consensus, it?s essential to note that the growth was driven by both the medical and industrial segments, which posted identical growth rates of 3% as well. The question is: can Varex sustain this momentum in the face of external pressures?

Margins and Earnings: Numbers That Tell a Story

Varex's GAAP gross margin held steady at 36%, while non-GAAP gross margin also reached 36%. The operating margins, however, tell a slightly different tale: GAAP operating margin was 10%, with non-GAAP at 12%. This slight divergence could indicate that while the company is managing its costs reasonably well, the underlying challenges are starting to pinch. Net earnings came in at $0.17 per diluted share on a GAAP basis, while non-GAAP EPS was a more robust $0.26, showcasing the importance of understanding earnings surprises in a nuanced way.

Cash Flow: A Bright Spot in an Uncertain Landscape

One positive takeaway is cash flow from operations, which stood at $17 million. This is a reassuring sign, particularly when you consider the broader economic context. Varex's cash, cash equivalents, and marketable securities totaled $226 million at the end of the quarter, excluding $125 million of restricted cash. This stable cash position should give the company some breathing room as it navigates the ongoing trade tensions.

Management's Insights: A Cautious Tone

Sunny Sanyal, CEO of Varex, commented on the demand dynamics, noting that while demand remains strong, the company is grappling with the impact of high tariffs imposed by China. Several China-based customers have paused their purchases, prompting Varex to temper its outlook for the near term. This caution is understandable; the trade landscape is as unpredictable as a cat on a hot tin roof.

Looking Ahead: Guidance for Q3

For the third quarter, Varex has provided a revenue forecast ranging between $180 million and $200 million, assuming a challenging environment with sales in China of approximately $10 million. The anticipated non-GAAP net earnings per diluted share range from -$0.05 to $0.10. This guidance underscores the company's cautious approach as it navigates a complex environment filled with both opportunities and challenges.

Conclusion: A Balancing Act

As Varex Imaging Corporation moves forward, it finds itself walking a financial tightrope. With a solid revenue base but a fluctuating external environment, analysts and investors alike will be watching closely for any signs of an earnings surprise in the upcoming quarters. For now, it appears that Varex is managing to keep its head above water, but the waves of market volatility could pose significant challenges ahead.